Unknown

Dataset Information

0

Modulation of amyloid-? aggregation by histidine-coordinating Cobalt(III) Schiff base complexes.


ABSTRACT: Oligomers of the A?42 peptide are significant neurotoxins linked to Alzheimer's disease (AD). Histidine (His) residues present at the N terminus of A?42 are believed to influence toxicity by either serving as metal-ion binding sites (which promote oligomerization and oxidative damage) or facilitating synaptic binding. Transition metal complexes that bind to these residues and modulate A? toxicity have emerged as therapeutic candidates. Cobalt(III) Schiff base complexes (Co-sb) were evaluated for their ability to interact with A? peptides. HPLC-MS, NMR, fluorescence, and DFT studies demonstrated that Co-sb complexes could interact with the His residues in a truncated A?16 peptide representing the A?42 N terminus. Coordination of Co-sb complexes altered the structure of A?42 peptides and promoted the formation of large soluble oligomers. Interestingly, this structural perturbation of A? correlated to reduced synaptic binding to hippocampal neurons. These results demonstrate the promise of Co-sb complexes in anti-AD therapeutic approaches.

SUBMITTER: Heffern MC 

PROVIDER: S-EPMC4166533 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Modulation of amyloid-β aggregation by histidine-coordinating Cobalt(III) Schiff base complexes.

Heffern Marie C MC   Velasco Pauline T PT   Matosziuk Lauren M LM   Coomes Joseph L JL   Karras Constantine C   Ratner Mark A MA   Klein William L WL   Eckermann Amanda L AL   Meade Thomas J TJ  

Chembiochem : a European journal of chemical biology 20140624 11


Oligomers of the Aβ42 peptide are significant neurotoxins linked to Alzheimer's disease (AD). Histidine (His) residues present at the N terminus of Aβ42 are believed to influence toxicity by either serving as metal-ion binding sites (which promote oligomerization and oxidative damage) or facilitating synaptic binding. Transition metal complexes that bind to these residues and modulate Aβ toxicity have emerged as therapeutic candidates. Cobalt(III) Schiff base complexes (Co-sb) were evaluated for  ...[more]

Similar Datasets

| S-EPMC4638226 | biostudies-literature
| S-EPMC7855930 | biostudies-literature
| S-EPMC6389928 | biostudies-literature
| S-EPMC3554264 | biostudies-literature
| S-EPMC3910297 | biostudies-literature
| S-EPMC3816745 | biostudies-literature
| S-EPMC6906786 | biostudies-literature
| S-EPMC9084250 | biostudies-literature
| S-EPMC3313626 | biostudies-literature
| S-EPMC7730246 | biostudies-literature